A randomized, crossover-controlled trial of intermittent and continuous transcutaneous electrical stimulation of genioglossus muscle for obstructive sleep apnea

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100050138

Enrollment

Unknown

Registered

2021-08-17

Start date

2021-09-01

Completion date

Unknown

Last updated

2022-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep apnea hypopnea syndrome

Interventions

Continuous transcutaneous electrical stimulation :Continuous transcutaneous electrical stimulation

Intermittent transcutaneous electrical stimulation :Intermittent transcutaneous electrical stimulation

sham stimulation:sham stimulation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Normal subjects; 2.Patients with simple snoring; 3.Patients with obstructive sleep apnea of different severity.

Exclusion criteria

Exclusion criteria: 1. Failure to sign written informed consent; 2. Implantation of cardiac pacemaker device; 3. Arrhythmia, especially without treatment; 4. Heart, liver, kidney and respiratory function damage; 5. Tumors and other chronic diseases; 6. Lack of independent behavior ability.

Design outcomes

Primary

Measure	Time frame
Apnea Hyponea Index (AHI);Snoring index (SI);oxygen desaturation index (ODI);	—

Secondary

Measure	Time frame
adverse reaction;tolerance;Epworth Sleepiness Scale (ESS);	—

Countries

China

Contacts

Public ContactKeHu

Renmin Hospital of Wuhan University

huke-rmhospital@163.com+86 18971035988

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 11, 2026